Bipolar radiofrequency renal denervation with the Vessix catheter in patients with resistant hypertension: 2-year results from the REDUCE-HTN trial

Affiliations

• ¹ CardioVascular Center Frankfurt CVC, Frankfurt, Germany.
• ² Neuroscience and Vascular Simulation Unit, Anglia Ruskin University, Chelmsford, UK.
• ³ Department of Cardiology, Universitäres Herz- und Gefäßzentrum, Hamburg, Germany.
• ⁴ Mercy Angiography, Auckland, New Zealand.
• ⁵ Department of Internal Medicine II, Paracelsus Medical University, Salzburg, Austria.
• ⁶ MonashHEART, Monash Health, Monash University, Melbourne, Australia.
• ⁷ Department of Cardiology, The Prince Charles Hospital, Brisbane, Australia.
• ⁸ APHP, Hôpital Européen Georges Pompidou, Hypertension Unit, Paris, France.
• ⁹ Department of Vascular Medicine and Hypertension, Paris Descartes University, Paris, France.
• ¹⁰ Peripheral Interventions, Boston Scientific Corporation, Marlborough, MA, USA.